Launch GMP manufacturing capacity for mRNA critical starting materials
Not delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 8 Jan 2024
- Due
- 31 Mar 2024
- Checked
- 25 Sep 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Launch GMP manufacturing capacity for mRNA critical starting materials”
What we found
Evidence strength A What the grades mean
The company failed to launch GMP manufacturing capacity for mRNA critical starting materials by the Q1 2024 deadline, subsequently pushing the expected availability to Q3 2024 and later to January 2025.
-
A Applied DNA Sciences Inc. 10-Q filed 2024-05-10
“GMP for Starting Materials | DNA critical starting materials for the production of mRNA therapies | Planned availability in Q3 of CY2024” ✓ confirmed on the page
Market reaction: the shares moved -14.5% against the S&P 500 over the three sessions around the disclosure (9 May 2024 to 14 May 2024). What this measures
Checked 25 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Capacity change
- Indicative materiality
- Medium rules
- Action
- Launch
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Applied DNA Sciences Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-BNBX-000012 · Corrections policy